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Abstract
Background: Epithelial cells and dendritic cells (DCs) both initiate and contribute to innate immune responses to 
bacteria. However, much less is known about the coordinated regulation of innate immune responses between GECs 
and immune cells, particularly DCs in the oral cavity. The present study was conducted to investigate whether their 
responses are coordinated and are bacteria-specific in the oral cavity.
Results: The β-defensin antimicrobial peptides hBD1, hBD2 and hBD3 were expressed by immature DCs as well as 
gingival epithelial cells (GECs). HBD1, hBD2 and hBD3 are upregulated in DCs while hBD2 and hBD3 are upregulated in 
GECs in response to bacterial stimulation. Responses of both cell types were bacteria-specific, as demonstrated by 
distinctive profiles of hBDs mRNA expression and secreted cytokines and chemokines in response to cell wall 
preparations of various bacteria of different pathogenicity: Fusobacterium nucleatum, Actinomyces naeslundii and 
Porphyromonas gingivalis. The regulation of expression of hBD2, IL-8, CXCL2/GROβ and CCL-20/MIP3α by GECs was 
greatly enhanced by conditioned medium from bacterially activated DCs. This enhancement was primarily mediated 
via IL-1β, since induction was largely attenuated by IL-1 receptor antagonist. In addition, the defensins influence DCs by 
eliciting differential cytokine and chemokine secretion. HBD2 significantly induced IL-6, while hBD3 induced MCP-1 to 
approximately the same extent as LPS, suggesting a unique role in immune responses.
Conclusions: The results suggest that cytokines, chemokines and β-defensins are involved in interaction of these two 
cell types, and the responses are bacteria-specific. Differential and coordinated regulation between GECs and DCs may 
be important in regulation of innate immune homeostasis and response to pathogens in the oral cavity.
Background
Epithelia throughout the body function as a physical bar-
rier against invading bacteria and also provide effective
innate immune defenses by producing antimicrobial pep-
tides [1-4]. The β-defensins are antimicrobial peptides
that are widely expressed in epithelial tissues including
the oral cavity [5-7]. They have a broad spectrum of activ-
ity against both Gram-negative and Gram-positive bacte-
ria as well as some fungi and viruses [2,8]. In addition to
their direct antimicrobial activity, human β-defensins
(hBDs) also directly stimulate antigen-presenting den-
dritic cells (DCs) and memory T cells, and thus can link
innate and adaptive immune responses [9-11]. They also
provoke efficient epithelial barrier repair to limit entry of
invading bacteria [12]. Antimicrobial peptides provide
multiple benefits as frontline defense molecules, and are
particularly important in the oral cavity in which the
health of the tissue depends on the balance between com-
mensal (non-pathogenic) and pathogenic microbes and
host defenses.
Human β-defensin 1 (hBD1) is constitutively expressed
by gingival epithelial cells (GECs), while the expression of
hBD2 and hBD3 is more variable and inducible. Epithelial
cells produce hBD2 following stimulation with microor-
ganisms (Gram-negative, Gram-positive bacteria and
Candida albicans) or cytokines such as TNF-α and IL-
1β[13-15]. The expression of the inducible hBD2 in GECs
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in vitro is regulated by several distinct signaling path-
ways, depending on the oral bacterial species. Commen-
sal bacteria such as Fusobacterium nucleatum and
Streptococcus gordonii induce hBD2 via MAPK pathways,
while periodontal pathogens such as Porphyromonas gin-
givalis and Aggregatibacter actinomycetemcomitans also
signal via NF-κB; in addition, P. gingivalis signals via pro-
tease-activated receptors [16-19]. This suggests that
GECs can distinguish commensal from pathogenic bacte-
ria. Nevertheless, purified bacterial LPS is a poor stimu-
lant for hBD2, and in vitro studies show that hBD2
induction is greatly amplified in epithelial cells when
monocyte/macrophage-like cells are included in the cul-
ture system [20,21].
Intestinal epithelial cells cross-talk with DCs, and coor-
dinately regulate the gut homeostasis in response to dif-
ferent bacteria [22]. DCs in the lamina propria take up
bacteria directly in the gut, [23,24] and mucosal DCs
induce divergent cytokine responses in response to com-
mensal and pathogenic bacteria [25]. In oral mucosa in
response to bacteria, GECs and DCs produce a wide
range of cytokines and chemokines, and DCs may play a
critical role during immune/inflammatory responses to
specific components within biofilms as part of the patho-
genesis of periodontal disease [26-28]. While there is
considerable information about innate responses in epi-
dermal keratinocytes and pulmonary epithelial cells
[20,21], much less is known about the coordinated regu-
lation of innate immune responses between GECs and
immune cells, particularly DCs in the oral cavity. We
hypothesized that DCs and GECs coordinately regulate
specific innate immune responses in response to oral bac-
teria. We used primary GECs and monocyte-derived DCs
to examine differential responses between these two cell
types  in vitro.  H e r e  w e  r e p o r t  t h a t  e x p r e s s i o n  o f  β -
defensins by both cell types is dependent on the bacterial
species, and that IL-1β from DCs mediates expression of
multiple responses in GECs. In addition, GECs also affect
the immune responses of DCs via their expression of
defensins. Our results underscore the importance of
functional coordination between GECs and DCs for pro-
moting characteristic innate immune responses in the
oral cavity.
Methods
Chemicals and Reagents
Bacterial crude cell wall extracts from F. nucleatum
(ATCC 25586), Actinomyces naeslundii (ATCC19039),
and  P. gingivalis (ATCC 33277) (FnCW, AnCW and
PgCW, respectively) were prepared as previously
described [14,29]. Antibodies used include mouse IgG
anti-human Langerin (Novocastra Laboratory Ltd., New-
castle, UK), rabbit polyclonal anti-hBD1 serum (kindly
provided by Dr. Tomas Ganz, UCLA), rabbit polyclonal
anti-hBD2 (Alpha Diagnostic International, San Antonio,
TX) and secondary antibodies biotin-conjugated donkey
anti-mouse (Jackson ImmunoResearch, West Grove, PA),
FITC-conjugated goat anti-rabbit (Vector Laboratories,
Burlingame, CA), FITC-conjugated donkey anti-goat IgG
(Jackson ImmunoResearch), and Texas Red-conjugated
streptavidin (Vector Laboratories). Recombinant human
IL-1 receptor antagonist (IL-1ra) was purchased from
R&D Systems (Minneapolis, MN). Human β-defensin 2
and 3 were purchased from Peptides International (Lou-
isville, KY).
Human primary gingival epithelial cell culture, stimulation 
and oral tissue model
Healthy human gingival tissue samples were obtained
from patients undergoing third-molar extraction at the
Oral Surgery Clinic, School of Dentistry, University of
Washington in accordance with IRB-approved proce-
dures. Cells were prepared for culture as previously
described [29]. The isolated primary human GECs were
cultured in serum-free keratinocyte basal medium sup-
plemented with keratinocyte growth factors (Cambrex,
Walkersville, MD) and grown to 80% confluence before
treatment with different stimulants. In some experi-
ments, GECs were treated before stimulation with human
IL-1 receptor antagonist, IL-1ra (100, 200, 400 ng/ml).
The organotypic tissue model consisted of normal
human oral keratinocytes, fibroblasts, and DCs (contain-
ing plasmacytoid DC and myeloid DC) in serum-free
medium to form a three-dimensional differentiated full
thickness tissue, which histologically is similar to gingival
mucosa (ORL-100, EpiOralFT™, MatTek Corporation,
Ashland, MA). Upon receipt, individual cell culture
inserts were placed at the air liquid interface in 6-well
plates with 5 ml of serum-free minimal media containing
growth factors (MatTek proprietary media) and rested
overnight (37°C, 5% CO2). Cultures were treated topically
with hBD2 or controls for 24 h, then fixed in 10% forma-
lin, embedded in paraffin, and sectioned for immunos-
taining.
Generation of monocyte-derived immature DC and 
treatments
Immature DCs (iDCs) were generated from human
peripheral blood mononuclear cell (PBMC), obtained
from healthy donors in accordance with approved IRB
procedures by Ficoll-Hypaque centrifugation, and nega-
tive and positive selection [30]. To obtain iDC, CD14+
monocytes were seeded at a density of 1 × 106 cells in 12-
well plates in 2 ml RPMI-1640 media supplemented with
10% fetal bovine serum (BioWhittaker, Walkersville,
MD), human granulocyte-macrophage colony-stimulat-
ing factor (100 ng/ml, Leukine; Amgen, Seattle, WA), and
human IL-4 (30 ng/ml; RDI, Flanders, NJ) and culturedYin et al. BMC Immunology 2010, 11:37
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for 6 days. Cells were fed on days 2 and 4 by replacing half
the medium and adding fresh cytokines. On day 6, the
cells exhibited an iDC phenotype, (CD1ahigh CD14-). For
maturation of the iDCs, cells were cultured for a further
24 h in the presence of E. coli lipopolysaccharide (LPS; 1
μg/ml; Sigma-Aldrich Inc., St Louis, MO), or with graded
doses of oral bacterial cell wall extracts (0.01 to 10 μg/ml).
The maturation of iDCs into mature DCs (mDCs) was
confirmed by FACS analysis for cell surface expression of
CD83 as described previously [30]. Conditioned media
were collected from iDCs treated with FnCW (10 μg/ml)
or PgCW (10 μg/ml) for 48 h. The resulting conditioned
media (CM-DCs) were briefly centrifuged and diluted
(1:2; 1:20) for stimulation of GECs.
RNA isolation and quantitative Real-time PCR
Total RNA was extracted using TRIzol (Invitrogen, Carls-
bad, CA) according to the manufacturer's suggestions.
Reverse transcription was performed with 2 μg of total
RNA (Ambion Inc., Austin, TX). Controls without
reverse transcriptase were included in each experiment.
Amplification of cDNA was carried out under standard
condition. Ribosomal phosphoprotein (RPO) was used as
a housekeeping gene. Quantitative real-time PCR was
conducted using the iCycler system (Bio-Rad, Hercules,
CA) with Brilliant SYBR Green QPCR Master Mix (Strat-
agene, La Jolla, CA). Each reaction contained 12.5 μl of
SYBR Green mix, 2 μl of cDNA, and 2 μM primers. The
amplification conditions were initial denaturation at 95°C
for 12 min followed by 40 cycles of denaturation at 95°C
for 30 s, annealing at 57-65°C for 30 s, and elongation at
72°C for 60 s. Melt-curve analysis was performed to con-
firm that the signal was that of the expected amplification
product. In initial experiments, amplification efficiency
was determined for all primer pairs. The primer pairs
used for quantitative real-time PCR were as follows:
hBD1: forward 5'-CACTTGGCCTTCCCTCTGTA,
reverse 5'- CGCCATGAGAACTTCCTACC; hBD3: for-
ward 5'- GTGAAGCCTAGCAGCTATGAGGAT, reverse
5'- TGATTCCTCCATGACCTGGAA. The oligonucle-
otides for RPO, hBD2, IL-8, CCL20 and CXCL2 (GROβ)
have been described previously [14,31]. Real-time PCR
was performed in duplicate and normalized to house-
keeping gene RPO. Results are expressed as the relative
fold increase of the stimulated over the controls, referred
to as Pfaffl's method [32].
HBD1, hBD2, hBD3 and RPO were amplified with spe-
cific primers and the PCR products were cloned with the
TOPO TA Cloning kit (Invitrogen). The pCR 2.1-TOPO
vector with the gene inserted was purified with PureLink
Quick Plasmid Miniprep Kit (Invitrogen) and linearized
with EcoRI (Promega, Madison, WI) restriction digest.
The linearized plasmid was visualized and quantified by
electrophoresis on a 1% agarose gel stained by ethidium
bromide. Each Real-time PCR was run with duplicates of
a series of seven ten-fold dilutions of the standard plas-
mid and a no-template control. The standard curve in
each run was constructed by plotting seven dilutions of
the standard plasmid DNA against the corresponding
threshold cycle value. The expression of hBD1, hBD2 and
hBD3 in GECs and DCs was calculated by the standard
curves of the samples containing known amounts of plas-
mid versus absolute expression value of RPO.
Detection of cytokines in culture supernatants
Human Cytokine Arrays III and V (Ray Biotech Inc., Nor-
cross, GA) were prepared as described by the manufac-
turer and used as a screening tool for detection of
multiple cytokines in culture media collected from
unstimulated and bacteria-stimulated GECs and DCs.
After iDCs were treated with various stimulants, the
supernatants were harvested, and levels of IL-1β, IL-6
and MCP-1 in culture medium were quantified by a sand-
wich ELISA technique (eBioscience, San Diego, CA).
Samples were analyzed in duplicate following the manu-
facturer's protocol. The detection limit of ELISA was 4
pg/ml.
Detection of β-defensin-2 and β-defensin-3 in GECs
GECs were grown in six-well plates and were treated at
80% confluence with AnCW (10 μg/ml), FnCW (10 μg/
ml), PgCW (1 μg/ml) or LPS (1 μg/ml) for 24 and 48 h.
Cells were washed three times with ice-cold PBS and
incubated with cell lysis buffer (Cell Signaling, Danvers,
MA) for 5 min at 4°. Protein extracts were obtained after
sonication of cell lysates and centrifugation at 7500 g at 4°
for 10 min. The hBD-2 and hBD3 ELISA development
Kits (PeproTech, Rocky Hill, NJ) were then used accord-
ing to the manufacturer's instructions. The detection
limit of hBD2 ELISA was 8 pg/ml. The detection limit of
hBD3 ELISA was 62 pg/ml.
Data analysis
Each experiment was performed from at least three dif-
ferent donors, and within an experiment, each test condi-
tion was performed in duplicate. Values are shown as the
Mean ± SD (standard deviation) or Mean ± SEM (stan-
dard error of the mean) from multiple experiments as
indicated. Statistical significance was determined using
one-way analysis of variance (ANOVA) among the
groups followed by the two-tailed t-test. All statistical
analysis was performed using JMP for Windows Release
6.0 (SAS Institute, NC). Differences were considered to
be statistically significant at the level of p < 0.05.
Results
Human defensin expression in DCs in vitro and in vivo
To determine whether DCs express β-defensins, we com-
pared the absolute gene expression levels in the absenceYin et al. BMC Immunology 2010, 11:37
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of bacteria between unstimulated iDCs and GECs by
quantitative real-time PCR using corresponding defensin
plasmids as a standard curve. HBD1, hBD2 and hBD3
expression in GECs was significantly higher than that in
iDCs (Figure 1A, B). HBD1, hBD2, and hBD3 expression
of GECs is 80, 150, and 2000 fold higher, respectively,
than that in iDCs. For both GECs and iDCs, the basal
level of expression of hBD1 was highest among all the β-
defensins. The expression level of hBD3 was much higher
than that of hBD2 in GECs, while hBD2 expression was
higher than that of hBD3 in DCs. Thus, both GECs and
DCs express detectable levels of β-defensins, although
the level is much lower in DCs.
Differential response of defensins to oral bacteria between 
DCs and GECs
To compare the regulation of defensin expression
between DCs and GECs, human iDCs and GECs were
treated with graded doses of cell wall preparations from
Gram-positive oral bacteria implicated in caries A.
naeslundii, Gram-negative non-pathogen F. nucleatum,
or Gram-negative periodontal pathogen P. gingivalis, and
E. coli LPS. Each of these stimulants induced DC matura-
tion on greater than 80% of cells as measured by expres-
sion of CD83 for mDCs [33].
Gene expression of both hBD1 and hBD2 mRNA was
induced in DCs by oral bacterial preparations (Figure 2A,
B), but the level of induction varied with different bacte-
ria.  A. naeslundii and  F. nucleatum stimulated greater
hBD1 expression than P. gingivalis (2-10 fold higher) at
the same dose (Figure 2A). Both A. naeslundii and  F.
nucleatum showed a bi-phasic hBD1 response with peak
expression (120-220 fold) at 0.1 ug/ml cell wall prepara-
tion, but 60-fold induction at 1 μg/ml. In contrast, P. gin-
givalis showed dose-dependent induction with only 20-
fold induction of hBD1 mRNA at 1 μg/ml. A. naeslundii
and F. nucleatum gave a dose-dependent stimulation of
hBD2 mRNA expression in DCs peaking at 16-18 fold
over unstimulated controls, while P. gingivalis was a less
effective inducer for hBD2 in DCs (Figure 2B). Controls
with LPS showed approximate 100-fold stimulation of
hBD1, but only minimal stimulation of hBD2 (< 5-fold).
HBD3 gene expression in DCs followed a similar trend of
hBD2 in response to bacterial preparation (Figure 2C).
However, the hBD-3 PCR product gave two peaks in
melting curve analysis in contrast to GECs. After elimi-
nating the possibility of primer dimers and genomic DNA
contamination, we assume these two peaks might be
unreported (un-annotated) splice variants of the gene of
interest in DCs. Further investigation will be performed
in the future to clarify the difference between the hBD3 in
DCs and GECs.
These results contrast with β-defensin expression in
GECs in which hBD1was constitutively expressed and not
altered by stimulation with bacteria, and hBD2 and hBD3
were induced in a dose-dependent manner by F. nuclea-
Figure 1 (A, B). Basal level of defensin gene expression in GECs and iDCs in the absence of bacteria. The absolute amount (picogram) of each 
defensin was determined using external plasmids standards in GECs (A) and iDCs (B). The expression of hBD1, hBD2 and hBD3 was normalized to 
housekeeping gene RPO. Results shown are the mean of three to five independent experiments. The error bars indicate SEM (standard error of mean).
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Figure 2 Differential defensins expression in response to oral bacteria by DCs and GECs. DCs (A, B, C) and GECs (D, E, F) were stimulated with 
graded doses of oral bacteria cell wall extracts (A. naeslundii, AnCW; F. nucleatum, FnCW; and P. gingivalis, PgCW) for 24 h. The gene expression of hBD1, 
2, and 3 was quantified by quantitative real-time PCR. LPS was used as a positive control. A, D. hBD1 expression; B, E. hBD2 expression; C. F. hBD3 
expression. Results are shown as mean fold change ± SEM over unstimulated controls. The data are average of three independent experiments per-
formed in duplicate. GECs were stimulated with bacterial preparation for 24 and 48 h. Proteins were harvested, and hBD2 and hBD3 proteins in GECs 
were measured by ELISA (G, H). The concentration of defensins range was pg/ml. Inductions of hBD2 and hBD3 proteins are as fold induction relative 
to unstimulated controls. The data are average of two independent experiments performed in duplicate. Error bars represent the mean ± SEM. Aster-
isks indicate statistically significant difference compared to unstimulated control (Ctl) (*p < 0.05).
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tum, but unlike with DCs, not induced much by A.
naeslundii and P. gingivalis (Figure 2D,E,F). LPS was not
effective in upregulating hBD2 and hBD3 gene expression
in epithelial cells at 24 h (Figure 2E, F).
Upregulation of hBD2 and hBD3 mRNA expression
was accompanied by a similar increase in protein level of
GECs as measured by ELISA (Figure 2G, H). GECs were
stimulated with various bacterial preparations at 24 and
48 h. The time-dependent increases of hBD2 and hBD3
protein levels were observed after exposure to various
bacterial preparations. HBD2 protein was significantly
expressed in response to F. nucleatum (both 24 h and 48
h) and A. naeslundii (48h) in GECs at 48 h, which is con-
sistent with the results obtained by mRNA gene expres-
sion at 24 h (Figure 2G). HBD3 protein was significantly
expressed in response to F. nucleatum, A. naeslundii and
LPS at 48 h, which is similar with trends observed by F.
nucleatum and A. naeslundii at 24 h. HBD3 protein was
significantly expressed in response to LPS at 48 h, which
was not seen at 24 h (Figure 2H).
DCs influence innate immune responses of GECs
In order to assess the influence of DCs on responses by
GECs, we added conditioned medium from stimulated
DCs to GEC cultures, and evaluated the expression of
hBD2, IL-8, CCL20/MIP-3a, and CXCL2/GROβ by GECs
in response to the cell wall preparations of F. nucleatum
and P. gingivalis. Expression of each of these genes was
markedly enhanced in the presence of DC-conditioned
medium compared to DC medium from unstimulated
c e l l s  a s  w e l l  a s  w h e n  c o m p a r e d  t o  t h e  r e g u l a r  G E C
medium (Figure 3). Upregulation of these innate immune
markers was 4- to 10-fold greater in the presence of DC-
conditioned medium than simple stimulation of GECs.
Conditioned medium from F. nucleatum-stimulated DCs
was more effective at stimulation of hBD2 and IL-8
mRNA than medium from P. gingivalis-stimulated DCs,
while medium from P. gingivalis-stimulated DCs yielded
equal or greater stimulation of CCL20 and CXCL2 gene
expression. These results suggest that stimulated DCs
enhance innate immune responses in GECs via secretion
of one or more bioactive effectors, and that the effect of
the DCs on GECs is dependent on the specific bacterial
stimulation.
In order to identify the bioactive effectors that mediate
the induction of hBD2 in GECs, and examine differential
responses by oral bacteria between GECs and DCs, we
initially evaluated cytokine/chemokine expression by
protein array analysis of the culture media from both DCs
and GECs after bacteria stimulation. P. gingivalis and F.
nucleatum both triggered DCs to produce cytokines IL-
1β IL-6 and IL-10 and GM-CSF as well as chemokine IL-
8. However, the chemokines RANTES, MCP-1, 2, and
TARC were upregulated more by F. nucleatum than P.
gingivalis (Figure 4A). In contrast, the results for GEC
stimulation, unlike with DCs, differed substantially for
the two bacterial preparations (Figure 4B). F. nucleatum-
treated GECs had increased expression of IL-6, IL-8,
GRO, and MCP-3, while P. gingivalis-treated GECs
increased MDC/CCL22 and reduced levels of ENA-78,
SDF-1, and GRO compared to unstimulated control cells.
One of the most striking differences between DCs and
GECs was IL-1β that was secreted by bacterially-stimu-
lated DCs but not by stimulated GECs. Because IL-1β is a
known inducer of hBD2, we quantified IL-1β by ELISA in
culture media. IL-1β production increased in a dose-
dependent manner in DC culture media after stimulation
with either F. nucleatum or P. gingivalis (Figure 4C). F.
nucleatum stimulation resulted in high levels of IL-1β in
DCs even at as little as 0.1 μg/ml, and induced approxi-
mately 30-fold more IL-1β than P. gingivalis at the same
dose. In contrast, IL-1β was not detected in the culture
media of GECs stimulated with at the same dose of bacte-
rial preparations (data not shown).
In order to test the functional role of IL-1β for hBD2
regulation, IL-1 receptor antagonist (IL-1ra) was added to
the co-culture system. GECs were pretreated with graded
doses of IL-1ra for 1 h, then stimulated with bacterial
preparations in the presence of DC- conditioned medium
(CM-DCs) with or without IL-1ra for 24 h. The IL-1ra
doses used in this study did not affect cell viability.
Recombinant IL-1ra partially blocked the expression of
hBD2 mRNA induced by F. nucleatum in the presence of
CM-DCs at 1:2 dilution (45-54%) (Figure 5A), and more
completely blocked hBD2 expression when the condition
medium was diluted tenfold (74-85%) (Figure 5B), com-
pared with F. nucleatum stimulation alone. IL-1ra nearly
completely blocked hBD2 expression in GECs stimulated
with P. gingivalis in the presence of CM-DC at both dilu-
tions (Figure 5C, D). IL-1ra also blocked CCL20, CXCL2
and IL-8 in P. gingivalis-stimulated cells in the same man-
ner as hBD2, but was less effective in blocking CCL-20
and CXCL2 expression induced by F. nucleatum-stimu-
lated GECs (data not shown). The fact that IL-1ra
blocked several innate immune responses suggests that
DC-derived IL-1β induces expression of these mRNA in
GECs and that IL-1β can function in the dialogue or
cross-talk between DCs and GECs.
GECs influence innate immune responses of DCs via 
defensins
To investigate how defensins from epithelial cells regulate
DC responses, we evaluated the effects of hBD2 and
hBD3 peptides on cytokines produced by DCs using
semi-quantitative protein array analyses and ELISA. An
overlapping but distinct profiling pattern of cytokines/
chemokines was observed with treatment by hBD2 and
hBD3 (Figure 6A). Both hBD2 and hBD3 treatment ofYin et al. BMC Immunology 2010, 11:37
http://www.biomedcentral.com/1471-2172/11/37
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iDCs resulted in increased secretion of GRO, IL-8, and
MCP-1. In addition, hBD2 increases the secretion of IL-6,
while hBD3 increased the secretion of TARC, PARC, and
TIMP-2. LPS treatment resulted in significant increases
in secretion of GRO, GRO-α, IL-6, IL-8, IL-10, and MCP-
1.
The differential secretion of IL-6 and MCP-1/CCL2 by
DCs treated with hBD2 and hBD3 was confirmed by
ELISA (Figure 6B, C). HBD2 treatment significantly
increased IL-6 secretion, although at much lower levels
than LPS. In contrast, hBD3 treatment induced MCP-1
secretion in DCs to approximately the same extent as
LPS.
In order to determine β-defensin interaction with DCs
in a tissue model system, hBD2 was applied to the epithe-
lial surface of a full-thickness mucosal tissue culture
model system and incubated for 24 h. HBD2 adhered to
DCs within the tissue model as detected by double label
immunostaining (Figure 7).
Discussion
Epithelial cells and DCs initiate and contribute to
immune responses; however, the coordination of specific
innate immune responses between these two cell types in
r e s p o n s e  t o  v a r i o u s  o r a l  b a c t e r i a  i s  n o t  c l e a r .  I n  t h i s
report, we show that both epithelial cells and DCs express
β-defensins and that products induced in response to oral
bacteria by one cell type influence the characteristic
responses of the other cell type. Apparently, the crosstalk
so well defined between B and T cells [34] also can occur
between GECs and DCs. Bacterially-activated DCs influ-
ence and significantly augment multiple innate immune
responses of epithelial cells as shown by the expression of
hBD2 as well as IL-8, CXCL2/GROβ and CCL-20/MIP3α
in epithelial cells. This amplification is primarily medi-
ated via IL-1β from DCs, since induction of these mRNAs
in GECs was largely attenuated by IL-1ra. On the other
hand, epithelial cells also influence the responses of DCs
as shown by selective stimulation of cytokine/chemokine
production by DCs in the presence of β-defensins. Fur-
thermore, the responses of both cell types are dependent
on the specific bacteria used for stimulation; this is dem-
onstrated by the unique profiles of β-defensin expression
as well as the differential cytokine/chemokine responses
of both cell types when stimulated by cell wall prepara-
tions of various bacteria of different pathogenicity: F.
nucleatum, A. naeslundii and P. gingivalis. Our findings
highlight the differential and coordinated regulation of
Figure 3 Gene expression of hBD2 and other innate immune makers in GECs in response to conditioned media from bacterially stimulated 
DCs. A. HBD2 mRNA upregulation in GECs in response to FnCW, and in the presence of conditioned medium (CM-DC, 1:2 dilution) from FnCW-stim-
ulated DCs for 24 h. HBD2 mRNA was poorly expressed in GECs stimulated with PgCW (1 μg/ml), but expression was enhanced by the conditioned 
medium (CM-DC, 1:2 dilution) from PgCW-stimulated DCs. Controls include epithelial cells in GEC medium with or without added bacteria, and in DC 
medium with or without bacteria. Data are expressed as mean fold changes of experimental duplicates relative to unstimulated GECs after normal-
ization to housekeeping gene RPO. Real-time PCR analysis of the additional markers for innate immunity (B, C, D) also show enhanced expression in 
GECs with conditioned medium from stimulated DCs (B: IL-8,C: CCL-20, D: CXCL2). Results are represented as mean ± SEM. *: p < 0.05 versus the rel-
ative control. Consistent results were obtained in two to three independent experiments for all markers.
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Figure 4 Array analysis of the released cytokines and chemokines in response to F. nucleatum and P. gingivalis in DCs and GECs. Each cy-
tokine or chemokine is represented by duplicate spots. Supernatants (1 ml) of unstimulated cells or cells stimulated for 24 h with FnCW or PgCW were 
applied to RayBio human cytokine protein array III as described in Materials and Methods. The rectangles in the upper left and lower right portions of 
the arrays indicate positive controls. The upregulated cytokines and chemokines are indicated by solid rectangles; down-regulated or absent products 
are indicated by dashed rectangles. The cytokine array image represents one of two independent experiments (A, B). ENA-78, epithelial neutrophil-
activating protein 78; GRO, growth regulated oncogene; MCP, macrophage colony stimulating factor; MDC, macrophage-derived chemoattractant; 
SDF-1, stromal cell-derived factor; TARC, thymus and activation-regulated chemokine. Note the upregulation of IL-1β in DCs with both bacterial prep-
arations (bold rectangle). C. IL-1β in the cultured media from DCs after FnCW or PgCW stimulation. The cells were stimulated with FnCW or PgCW at 
the indicated dose and time points. The culture media were collected and IL-1β was quantified by ELISA. Results are represented as mean ± SD for 
two determinations in a representative experiment. Similar results were obtained with conditioned media from three different donors. (**: p < 0.001; 
*: p < 0.05). Ctl: medium only.
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innate response in response to oral bacteria. These find-
ings confirm previous studies and provide additional
insights into how these two cell types interact in a net-
work that may result in optimal immune regulation in
response to various oral bacteria.
The β-defensins are mainly expressed by epithelial cells,
although hBD1, but not hBD2, was previously detected in
mature DCs, monocytes, and macrophages in response to
LPS [35]. Our results show both hBD1 and hBD2 are
expressed in DCs with basal level in iDCs approximately
100-fold lower than in epithelial cells. However, in con-
trast to epithelial cells, in which hBD1 is constitutively
expressed and hBD2 and 3 are inducible, both hBD1 and
hBD2 were inducible in DCs by bacterial exposure, while
hBD3 was only weakly expressed. Furthermore, hBD2 dif-
fusing from the epithelium associated with DCs as shown
in an oral full thickness tissue model (Figure 7). Both
hBD2 and hBD3 modulated expression of chemokines by
DCs including IL-8 and GRO with differential dose-
dependent upregulation of IL-6 by hBD2 and MCP-1 by
hBD3. Our results agree and extend previous observa-
tions that β-defensins influence DC properties. Both
hBD1 and hBD3 influence DC maturation with upregula-
tion of costimulatory molecules [36,37], and hBD1 also
stimulates expression of proinflammatory cytokines [37].
Oral bacteria differ in their effectiveness in inducing
hBD1, hBD2 and hBD3 mRNA and proteins in GECs and
DCs. The Gram-negative commensal, F. nucleatum, was
more effective than a Gram-positive cariogenic bacte-
rium, A. naeslundii, and both are more effective than the
periopathogen P. gingivalis in upregulation of hBD1, 2
and 3 in DCs. This dose response pattern is similar to that
shown by Chino et al [33] for chemokine and cytokine
secretion by DCs. In addition, in DCs, hBD1 showed a bi-
phasic response to the non-pathogens similar to the
expression of MCP-1, while hBD2 expression was dose-
dependent, similar to the IL-8 response [33]. Maturation
of DCs was induced by direct exposure to oral bacteria
[33] and by hBD3 [36] which is highly expressed by epi-
thelial cells in response to F. nucleatum (Figure 2). Thus,
Figure 5 Effects of IL-1ra on bacterially-induced hBD2 in cultured GECs. Cells were stimulated by conditioned medium from DCs (CM-DCs) treat-
ed with FnCW (A, B) at 1:2 (A) or 1:20 dilution (B); or PgCW at 1:2 (C) and at 1:20 dilution (D) with or without IL-1ra (100, 200, 400 ng/ml). Expression 
of mRNA was analyzed by real-time PCR. Data are expressed as mean fold change of experimental duplicates compared to the expression of unstim-
ulated cells for each condition after normalization to housekeeping gene RPO. Results are represented as mean of fold change ± SD for two determi-
nations in a representative experiment. Similar results were obtained with cells from three different donors. Values are significantly different compared 
to the respective control (*: p < 0.05).
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Figure 6 A. Cytokine profiling in DCs stimulated with hBD2, hBD3 and LPS B, C. Assay of IL-6 and MCP-1 in culture media from DCs stimu-
lated by β-defensins by ELISA. A: The iDCs were treated with hBD2 (10 μg/ml), hBD3 (10 μg/ml), LPS (1 μg/ml) and untreated control for 24 h. Su-
pernatants were analyzed by protein array as in Figure 4. The most differentially regulated cytokines are identified by arrow. B, C: The iDCs were 
stimulated with hBD2 (10 μg/ml) and hBD3 (10 μg/ml) at the indicated dose. The culture media were collected and IL-6 (B) and MCP-1 (C) were quan-
tified by ELISA. Results are represented as mean ± SEM for three determinations from independent experiments. Note the difference in scale of B (right 
and left axis). HBD2 stimulated significantly greater IL-6 than hBD3, while hBD3 produced significantly greater MCP-1 than hBD2 (*: p < 0.05: **: p < 
0.001).
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Figure 7 (A-D). HBD2 associates with DCs in an oral tissue model. HBD2 peptide was applied for 6 or 18 h to the surface of oral full thickness tissue 
model containing DCs. Immunohistochemical reaction of hBD2 polyclonal antibody (negative image) showing reaction in the upper layers of the ep-
ithelium and in a scattered distribution within the connective tissue. B-D. Double label immunofluroesence of an area similar to that indicated by the 
box in A, B. Double label; Anti-human HLA-DR monoclonal antibody with biotinylated anti-mouse IgG made in goat, streptavidin Alexafluor 594 (red) 
and anti-hBD2 polycloonal antibody made in rabbit with Alexafluor 488 labeled anti-rabbit IgG made in goat (green). C. HBD2 immunolocalization 
only (green). D. HLA-DR immunolocalization only (red). The solid green line visible in B and C is the supporting membrane for the tissue model. Con-
trols without primary antibody were negative. Experimental control without added hBD2 showed no green fluorescence associated with HLA-DR pos-
itive cells. Original magnification: A: 20×, B, D: 60×.Yin et al. BMC Immunology 2010, 11:37
http://www.biomedcentral.com/1471-2172/11/37
Page 12 of 14
low doses of commensal bacteria may play a role in
immune surveillance by DCs under non-inflammatory
conditions both by direct contact and by cross-talk from
epithelial cells via β-defensins. On the other hand, epithe-
lial cells also respond differently to different types of bac-
teria, as hBD2 and 3 gene expression is greatly induced by
F. nucleautm, consistent with the immune-regulatory
properties of this bacterium [31]. With greater exposure
to commensal bacteria, or under inflammatory condi-
tions, responses would be enhanced by secretion of IL-1β
by DCs that stimulates epithelial cell expression of hBD-2
and CCL20, GRO and IL-8. The defensins further stimu-
late IL-6 and MCP-1 secretion by DCs, which might help
to amplify the appropriate immune responses. Thus, epi-
thelial cells and DCs may work together to express anti-
microbial peptides and attract monocytes and
neutrophils to fight infection in the gingival crevice, a
critical factor for the health of the periodontium
[27,38,39].
IL-1β, secreted by DCs, is the main cytokine responsi-
ble for mediating increased hBD2 expression in GECs, as
previously demonstrated in epidermal keratinocytes and
pulmonary epithelial cells [20,21]. IL-1ra also attenuated
upregulation of other innate immune markers (CCL20,
CXCL2) in parallel with that of hBD2. Thus, IL-1β can
function in the dialogue or cross-talk between DCs and
GECs. However additional factors, such as RANTES,
which are differentially secreted by DCs treated with F.
nucleatum  vs. P. gingivalis, may also contribute to this
cross-talk since IL-1ra was only partially effective in
blocking F. nucleatum induced responses. Indeed, P. gin-
givalis (in the absence of its proteases) is a poor stimulant
for hBD2 in GECs. However, the GECs can respond to
conditioned medium from DCs stimulated with P. gingi-
valis, suggesting the importance of multiple cell types in
the response in situ.
Epithelial secretion of defensins and chemokines that
attract neutrophils is much reduced in the presence of the
pathogen,  P. gingivalis, consistent with its 'stealth-like'
properties [40,41]. However, in response to this pathogen,
epithelial cells secreted MDC/CCL22, an inflammatory
chemokine that induces Th2 effector responses [42].
These trends could be related to events in gingival
inflammation and periodontal disease. Jotwani and
coworkers suggested that the prominent response in P.
gingivalis-mediated periodontal disease is a Th2 effector
response [43], supported by our findings. However, we
did not find secretion of IL-8 or MCP-1 with our P. gingi-
valis cell wall stimulation in contrast to Kusumoto et al
[44], which used a sonicated extract of P. gingivalis. Neu-
trophil chemotaxis is critical for periodontal health, and
this process is interrupted in periodontal disease com-
monly associated with P. gingivalis [38,39]. IL-8 is
expressed in F. nucleatum-stimulated GECs, and its
expression is strongly enhanced by interaction with DCs
stimulated with this commensal bacteria. However, over-
all levels are low in P. gingivalis-stimulated GECs and in
the combination of P. gingivalis-stimulated DCs and
GECs. Thus, both DCs and GECs distinguish between
these bacteria and have specific responses.
The ability of DCs to stimulate immune responses is
related to their activation and maturation status, and acti-
vated DCs are significant sources of chemokines that
recruit other immune cells, including T cells, natural
killer cells, monocytes and additional DCs [28]. The oral
bacterial preparations used here induced the maturation
of DCs, in agreement with our previous studies [33], as
assessed by up-regulation of surface expression of CD83
(data not shown). Interestingly, both hBD2 and hBD3
induced the maturation of DCs as well, although to a
lower extent (10%-30%) than that of bacteria prepara-
tions. Defensin treatment produced differential cytokine/
chemokine profiles in DCs. Both hBD2 and hBD3
induced IL-8, GRO and MCP-1, in agreement with the
findings in peripheral blood mononuclear cells [45].
However, DCs respond differently to hBD2 and hBD3;
hBD2 induced IL-6, while hBD3 induced greater levels of
MCP-1 than hBD2. The induction of IL-6 and IL-8 may
be particularly important in attracting neutrophils and T
helper 17 cells [46]. Multiple chemokines, including
GRO, have microbicidal effects on both Gram-positive
and Gram-negative bacteria [47]. MCP-1 acts as an
attractant for monocytes and T-regs [48]. We also
observed the increased secretion of TARC, PARC, and
TIMP-2 in hBD3-treated DCs, which may attract more
immune cells in situ. The evidence that hBD2 and 3
induced selective cytokine expression suggests that these
defensins may play unique role in immune responses due
to utilizing different receptors to stimulate DCs; TLR4,
CCR6 and CD91 have been implicated as receptor for
hBD2 [9,37,49] and TLR1 and TLR2 as receptors for
hBD3 [36].
An intimate interaction between epithelial cells and
DCs has been described in the gut to maintain immune
homeostasis in response to various bacteria [50,51]. Our
results for the first time demonstrate that a similar phe-
nomenon of specific bacteria response coordinately may
occur in the oral mucosa. Our findings show that DCs
amplified the bacterially specific innate immune
responses of GECs, while epithelial-derived defensins
induced unique chemokine patterns, suggesting the exis-
tence of autoregulatory loop between DCs and GECs.
GECs and DCs evoke characteristic cytokine patterns
upon exposure to different bacterial stimuli and coordi-
nately enhance each other's innate immune responses.
Not only do defensins act as chemoattractants to immune
cells, but we found that defensins also induce unique
cytokine patterns, which could be crucial in amplifyingYin et al. BMC Immunology 2010, 11:37
http://www.biomedcentral.com/1471-2172/11/37
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immune responses to oral bacteria. These responses and
cross-talk may result in discriminatory signals within oral
tissue and gingiva in particular, and yield characteristic
and appropriate immune responses in the state of health
in the presence of non-pathogenic bacteria, and with
inflammation in the presence of pathogens.
Conclusions
The results suggest that cytokines, chemokines and β-
defensins are involved in the interaction of DCs and
GECs, and the responses are bacteria-specific. Differen-
tial and coordinated regulation between these two cell
types may be important in the regulation of innate
immune homeostasis and responses to pathogens in the
oral cavity.
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